Caroline Roussel-Maupetit

Caroline Roussel-Maupetit co-founded Advicenne and has served as the company’s Director of Operations since its inception in 2007.

Having participated in the creation of three French biotechnology companies, Caroline brings to her work at Advicenne an extensive background in the pharmaceutical development of innovative therapeutic products, in particular in its technical and regulatory aspects, and in the area of subcontracting management.

In 1995, Caroline co-founded Syn:tem, a French biotech company focused on the treatment of oncology, pain management and diseases of the central nervous system, serving as the company’s Chief Operating Officer until its acquisition by CLL Pharma SA in 2005. Prior to founding Synt:em, she served as Marketing Manager for Protein Performance, a company specializing in the development of recombinant proteins.

Caroline holds degrees in industrial biological engineering from the University of Technology of Compiègne (UTC) and in management from IEDE Montpellier.